Gulf International Bank UK Ltd Has $1.85 Million Position in Humana Inc. (NYSE:HUM)

Key Points

• Gulf International Bank UK Ltd has reduced its holdings in Humana Inc. by 28.6%, owning 6,977 shares valued at approximately $1.85 million after selling 2,790 shares in the first quarter.
• Several institutional investors, including Cary Street Partners and Riverview Trust Co, have increased their investments in Humana, reflecting a general trend of strong institutional ownership at 92.38% of the company's stock.
• Humana reported $6.27 earnings per share for its last quarter, slightly missing analyst estimates, but showed a healthy revenue of $32.39 billion, which was above predictions.

Gulf International Bank UK Ltd lowered its stake in Humana Inc. (NYSE:HUM - Free Report) by 28.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,977 shares of the insurance provider's stock after selling 2,790 shares during the quarter. Gulf International Bank UK Ltd's holdings in Humana were worth $1,846,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of HUM. Deutsche Bank AG raised its position in Humana by 18.2% in the fourth quarter. Deutsche Bank AG now owns 631,371 shares of the insurance provider's stock worth $160,185,000 after acquiring an additional 97,071 shares in the last quarter. Janney Montgomery Scott LLC bought a new stake in Humana in the first quarter worth about $1,309,000. Fred Alger Management LLC bought a new stake in Humana in the fourth quarter worth about $451,000. Clearline Capital LP bought a new stake in Humana in the fourth quarter worth about $1,102,000. Finally, Envestnet Asset Management Inc. raised its position in Humana by 2.4% in the first quarter. Envestnet Asset Management Inc. now owns 125,684 shares of the insurance provider's stock worth $33,256,000 after acquiring an additional 2,950 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on HUM. Bank of America decreased their price objective on shares of Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a research note on Tuesday, June 17th. Morgan Stanley reduced their target price on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 target price on shares of Humana in a research note on Thursday, May 1st. Piper Sandler dropped their price objective on Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a research note on Thursday, July 31st. Finally, Barclays set a $275.00 price objective on Humana and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. Seventeen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $281.43.

Humana Trading Up 1.9%

HUM traded up $5.39 during midday trading on Friday, reaching $286.73. 1,738,591 shares of the company were exchanged, compared to its average volume of 2,075,797. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a one year low of $206.87 and a one year high of $382.72. The stock has a market capitalization of $34.49 billion, a P/E ratio of 22.01, a PEG ratio of 1.68 and a beta of 0.44. The stock's 50-day simple moving average is $242.70 and its 200 day simple moving average is $253.54.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%. The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same quarter last year, the business posted $6.96 EPS. Humana's quarterly revenue was up 9.6% on a year-over-year basis. As a group, analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.